ADXN
Addex Therapeutics LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.65M
P/E Ratio
—
EPS
$-9.15
Beta
1.98
52W High
$12.05
52W Low
$5.41
50-Day MA
$6.64
200-Day MA
$7.87
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Addex Therapeutics Ltd
Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland.
Fundamentals
| Revenue (TTM) | 173,000 |
| Gross Profit (TTM) | -499,000 |
| EBITDA | $-2.81M |
| Operating Margin | -4882.00% |
| Return on Equity | -87.50% |
| Return on Assets | -15.90% |
| Revenue/Share (TTM) | $0.24 |
| Book Value | $7.78 |
| Price-to-Book | 1.43 |
| Price-to-Sales (TTM) | 49.98 |
| EV/Revenue | 185.53 |
| EV/EBITDA | -0.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 959.00% |
| Shares Outstanding | $1.27M |
| Float | $92.72M |
| % Insiders | 0.00% |
| % Institutions | 0.05% |
Historical Volatility
HV 10-Day
34.98%
HV 20-Day
38.71%
HV 30-Day
64.59%
HV 60-Day
72.21%
HV Rank
19.8%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026